Our Team Archive - Page 3 of 16

Sara Buhrlage, PhD, Ronny Drapkin, MD, PhD & Jarrod Marto, PhD

Project Title: “Harnessing Epigenetic Alterations in the Fallopian Tube to Develop Early Interception Strategies in Ovarian Cancer”

Dr. Buhrlage is an Associate Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and a principal investigator in the Department of Cancer Biology at Dana-Farber Cancer Institute. Dr. Drapkin is Associate Professor of Pathology in the Department of Obstetrics & Gynecology at the University of Pennsylvania and serves as Director of the Penn Ovarian Cancer Research Center (OCRC), the Director of Gynecologic Cancer Research at the Basser Center for BRCA, and Director of the Ovarian Cancer Translational Center of Excellence at the Abramson Cancer Center. Dr. Marto is an Associate Professor of Pathology at Harvard Medical School and also a principal investigator in the Department of Cancer Biology at Dana-Farber Cancer Institute. In addition, he is the Director of the Blais Proteomics Center and co-Director along with Dr. Buhrlage of the new Center for Emergent Drug Targets at Dana-Farber Cancer Institute.

DIPANJAN CHOWDHURY, PhD & KEVIN ELIAS, MD

Project Title: “Personalized screening for ovarian cancer using circulating miRNA risk profiles”

Dr. Chowdhury is a Professor of Medicine at Dana-Farber Cancer Institute/ Harvard Medical School and the Chief of the Division Of Radiation and Genomic Stability and Co-Director of the Center for BRCA and Related Genes. Dr. Elias is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Gynecologic Oncologist and Director of the Gynecologic Oncology Laboratory at Brigham And Women’s Hospital.

Tal Danino, PhD & Ronny Drapkin, MD, PhD

Project Title: “Engineering probiotics for early detection and interception of ovarian cancer”

Dr. Danino is an Associate Professor in the Department of Biomedical Engineering at Columbia University. Dr. Drapkin is an Associate Professor of Pathology in the Department of Obstetrics & Gynecology at the University of Pennsylvania and serves as Director of the Penn Ovarian Cancer Research Center (OCRC), the Director of Gynecologic Cancer Research at the Basser Center for BRCA, and Director of the Ovarian Cancer Translational Center of Excellence at the Abramson Cancer Center

About Team Science Grants

The Tina’s Wish Team Science Grant (formerly the Individual Investigator Grant) encourages collaboration in pursuit of an effective screen for the early detection or a prevention strategy for ovarian cancer. The Team Science Grant is $400,000 over two (2) years.

Kelly Cancelmo

Kelly brings several years’ experience in non-profit communications, development, and event planning to her work at Tina’s Wish. A graduate of The Catholic University of America, Kelly spent her college years building her leadership skills through volunteerism and athletics. She cares deeply about women’s health issues and is happy to add her talents to the Tina’s Wish team.

Olivia Maloney

Olivia joined Tina’s Wish following her time on the development team at another non-profit organization in New York City. She graduated from Tulane University with a B.S. in Public Health and Psychology, and is especially passionate about women’s health. She is thrilled to be a part of the Tina’s Wish team, and is eager to help all women have a fighting chance against ovarian cancer!

Enter your keyword

Archives